New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

The survey of 21,753 people, including nearly 3,500 cancer survivors, found alarmingly low levels of trust in experts, with ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...